Cypris, a leading AI-powered research platform for R&D teams, is excited to announce the appointment of Chris Staymates as Chief Technology Officer (CTO), previously the Chief Innovation Officer at ...
KLS-1 is under clinical development by Vector Vitale and currently in Phase II for Metastatic Melanoma. According to GlobalData, Phase II drugs for Metastatic Melanoma have a 36% phase transition ...